Circulatory miRNA as a Biomarker for Therapy Response and Disease-Free Survival in Hepatocellular Carcinoma

SIMPLE SUMMARY: In the present study, we identified new prognostic serum miRNA biomarkers to predict therapy response and disease-free survival according to different therapeutic strategies in hepatocellular carcinoma (HCC). MiR-4443, miR-4454, and miR-4530 were significantly related to treatment re...

Descripción completa

Detalles Bibliográficos
Autores principales: Pratama, Muhammad Yogi, Visintin, Alessia, Crocè, Lory Saveria, Tiribelli, Claudio, Pascut, Devis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601056/
https://www.ncbi.nlm.nih.gov/pubmed/33003646
http://dx.doi.org/10.3390/cancers12102810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601056/
https://www.ncbi.nlm.nih.gov/pubmed/33003646
http://dx.doi.org/10.3390/cancers12102810

Ejemplares similares